Essais liés6clinical trials
VilleBoca Ratonlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07781644

Ouvrir le site du centre

Essais cliniques associés

6
MoléculeIndication / populationPhaseNCTTitreStatut
RO7568282 Parkinson Phase 2 NCT07781644 TARBELA-PD — Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease RECRUITING
Prasinezumab Parkinson Phase 2 NCT04777331 PADOVA — A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease ACTIVE_NOT_RECRUITING
RO7046015 Parkinson Phase 2 NCT03100149 PASADENA — A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease ACTIVE_NOT_RECRUITING
NEU-411 Parkinson Phase 2 NCT06680830 NEULARK — A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease RECRUITING
Prasinezumab Parkinson Phase 3 NCT07174310 PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease RECRUITING
CVN424 75 mg Parkinson Phase 3 NCT06553027 To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications ACTIVE_NOT_RECRUITING